Beida Pharmaceutical: Shareholder Terry Si intends to reduce his stake by no more than 0.71%.

Beida Pharmaceutical announced that Hangzhou Terixi Creation Enterprise Management Partnership Enterprise, which holds 28,797,100 shares, accounting for 6.84% of the shares, plans to reduce its holdings by no more than 3 million shares, accounting for 0.71%, through centralized bidding or block trading from May 8, 2026 to August 7, 2026.